| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional) |
|
Oral Immunology, Immunopathology & Immunotherapy, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
RFA-AT-21-001 |
R01 |
|
|
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional) |
|
Oral Immunology, Immunopathology & Immunotherapy, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
RFA-AT-21-002 |
R21 |
|
|
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) |
|
Common Fund Programs |
RFA-RM-20-019 |
R03 |
|
|
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) |
|
Tissue Engineering & Regenerative Medicine |
RFA-DE-20-006 |
R01 |
|
|
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) |
|
Tissue Engineering & Regenerative Medicine |
RFA-DE-20-007 |
R21 |
|
|
| Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) |
|
Behavioral & Social Science, COVID-19, Oral Health Disparities & Inequities, Dissemination & Implementation Science |
RFA-OD-20-013 |
U24 |
|
|
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) |
|
Common Fund Programs |
RFA-RM-20-012 |
DP2 |
|
|
| Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
|
Clinical Research & Clinical Trials |
PAR-20-167 |
R00, SI2 |
|
|
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) |
|
Common Fund Programs |
RFA-RM-20-014 |
DP5 |
|
|
| NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional) |
|
Common Fund Programs |
RFA-RM-20-021 |
DP5 |
|
|
| Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
|
Clinical Research & Clinical Trials, HIV/AIDS & Oral Health |
PAR-18-190 |
R21 |
|
|
| Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
|
Clinical Research & Clinical Trials, HIV/AIDS & Oral Health |
PAR-18-189 |
R01 |
|
|
| NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) |
|
Common Fund Programs |
RFA-RM-20-011 |
DP1 |
|
|
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) |
|
Common Fund Programs |
RFA-RM-20-013 |
R01 |
|
|
| NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) |
|
Common Fund Programs |
RFA-RM-20-020 |
R01 |
|
|
| Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) |
|
Tissue Engineering & Regenerative Medicine, Clinical Research & Clinical Trials |
RFA-HL-21-003 |
UG3, UH3 |
|
|
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) |
|
Career Development, Training & Fellowships |
PAR-19-038 |
K43 |
|
|
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) |
|
Career Development, Training & Fellowships |
PAR-19-098 |
K43 |
|
|
| Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) |
|
Global Health, Training & Fellowships |
PAR-18-901 |
D43 |
|
|
| Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) |
|
COVID-19, Oral Health Disparities & Inequities |
PAR-20-237 |
R01 |
|
|
| Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) |
|
Clinical Research & Clinical Trials, Parent Announcements & Trans-NIH Announcements |
PAR-18-950 |
X02 |
|
|
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed) |
|
Craniofacial & Dental Development, Disorders, Craniofacial Skeletal Biology & Pathobiology, Small Business (SBIR/STTR), Technology Development |
PA-18-609 |
R41, R42 |
|
|
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed) |
|
Craniofacial & Dental Development, Disorders, Craniofacial Skeletal Biology & Pathobiology, Small Business (SBIR/STTR), Technology Development |
PA-18-610 |
R43, R44 |
|
|
| Research on Transgender Health (R21) |
|
Behavioral & Social Science |
PA-17-477 |
R21 |
|
|
| Research on Transgender Health (R01) |
|
Behavioral & Social Science |
PA-17-478 |
R01 |
|
|
